Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-28 Sale | 2019-07-02 8:11 pm | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,873 | $45 | $129,285 | 109,199 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-08 Tax Withholding | 2021-03-10 5:38 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 5,221 | $33.37 | 147,346 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 7:25 pm | N/A 2031-02-24 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 60,700 | $0 | 192,467 (Direct) | View |
| 2020-12-07 Tax Withholding | 2020-12-09 7:33 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,728 | $41.99 | 131,767 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 4:52 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 7,082 | $14.57 | 134,495 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 4:52 pm | N/A 2024-03-19 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 7,082 | $0 | 134,495 (Direct) | View |
| 2020-09-08 Tax Withholding | 2020-09-10 7:32 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,728 | $42.16 | 127,413 (Direct) | View |
| 2020-06-08 Tax Withholding | 2020-06-10 7:45 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,728 | $33.61 | 130,141 (Direct) | View |
| 2020-03-06 Tax Withholding | 2020-03-18 8:03 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 6,525 | $39.71 | 194,691 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-18 8:03 pm | N/A 2030-03-17 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 100,000 | $0 | 194,691 (Direct) | View |
| 2019-12-06 Tax Withholding | 2019-12-09 8:13 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,442 | $47.39 | 101,216 (Direct) | View |
| 2019-09-06 Tax Withholding | 2019-09-10 8:31 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 5,541 | $41.68 | 103,658 (Direct) | View |
| 2019-06-18 Exercise | 2019-06-20 6:19 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 16,000 | $14.57 | 119,154 (Direct) | View |
| 2019-06-18 Exercise | 2019-06-20 6:19 pm | N/A 2024-03-19 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 16,000 | $0 | 119,154 (Direct) | View |
| 2019-06-06 Tax Withholding | 2019-06-07 7:36 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,058 | $38.31 | 96,072 (Direct) | View |
Ownership | 2019-05-09 9:02 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 0 | $0 | 321,405 (Direct) | View |